Literature DB >> 6781799

IgA glomerulonephritis (Berger's disease): evidence of high serum levels of polymeric IgA.

M L Trascasa, J Egido, J Sancho, L Hernando.   

Abstract

Eleven out of 15 patients with IgA mesangial glomerulonephritis (Berger's disease) had an increased proportion of serum IgA in 9-21S fractions on 5-40% sucrose density-gradient ultracentrifugation; the heavier fractions decreased at acid pH. Serum IgA purified by starch electrophoresis was subjected to reduction-alkylation yielding fragments of lower molecular weight. J chain was detected on urea alkaline polyacrylamide electrophoresis and the high-molecular weight IgA bound the human secretory component. In six patients treated with phenytoin for 1 year there was a decrease in polymeric IgA and an increase in monomeric IgA adopting a pattern similar to that of the controls. Our results show the presence of a large amount of true IgA polymers, partially as immune complexes, in the serum of patients with Berger's disease. These data together with their normalization after phenytoin treatment may open a new pathogenic and therapeutic approach to this entity.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6781799      PMCID: PMC1537109     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  21 in total

1.  The clinical course of IgA nephropathy in adults.

Authors:  J van der Peet; L Arisz; J R Brentjens; J Marrink; P J Hoedemaeker
Journal:  Clin Nephrol       Date:  1977-08       Impact factor: 0.975

2.  Increase of IgA-bearing lymphocytes in peripheral blood from patients with IgA nephropathy.

Authors:  Y Nomoto; H Sakai; S Arimori
Journal:  Am J Clin Pathol       Date:  1979-02       Impact factor: 2.493

3.  [Proceedings: Mesangial glomerulonephritis with IgA deposits: study of serum immunoglobulins].

Authors:  G Lagrue; G Hirbec; M Fournel; L Intrator
Journal:  J Urol Nephrol (Paris)       Date:  1974 Apr-May

4.  IgA nephropathy.

Authors:  R C McCoy; C R Abramowsky; C C Tisher
Journal:  Am J Pathol       Date:  1974-07       Impact factor: 4.307

5.  IgA glomerular deposits in renal disease.

Authors:  J Berger
Journal:  Transplant Proc       Date:  1969-12       Impact factor: 1.066

6.  Isolation of human secretory component by affinity chromatography on IgM-sepharose.

Authors:  B J Underdown; J DeRose; K Koczekan; D Socken; J Weicker
Journal:  Immunochemistry       Date:  1977-02

7.  IgA and glomerular disease.

Authors:  J A Whitworth; S Leibowitz; M C Kennedy; J S Cameron; C Chantler
Journal:  Clin Nephrol       Date:  1976-01       Impact factor: 0.975

8.  IgA deficiency, epilepsy, and phenytoin treatment.

Authors:  J Seager; D L Jamison; J Wilson; A R Hayward; J F Soothill
Journal:  Lancet       Date:  1975-10-04       Impact factor: 79.321

9.  Electrophoretic heterogeneity of polypeptide chains of specific antibodies.

Authors:  R A Reisfeld; P A Small
Journal:  Science       Date:  1966-05-27       Impact factor: 47.728

10.  [Isolation and immunochemical study of monomer and dimer forms of IgA human globulins].

Authors:  E M Gavrilova; A M Egorov; K L Shakhanina
Journal:  Biokhimiia       Date:  1976-04
View more
  46 in total

1.  Detection and characterization of circulating and glomerular immune complexes in experimental IgA nephropathy.

Authors:  J González-Cabrero; J Egido; A Barat; E González
Journal:  Immunology       Date:  1990-07       Impact factor: 7.397

2.  The glycans deficiencies of macromolecular IgA1 is a contributory factor of variable pathological phenotypes of IgA nephropathy.

Authors:  L-X Xu; Y Yan; J-J Zhang; Y Zhang; M-H Zhao
Journal:  Clin Exp Immunol       Date:  2005-12       Impact factor: 4.330

3.  Association of a single-nucleotide polymorphism in the immunoglobulin mu-binding protein 2 gene with immunoglobulin A nephropathy.

Authors:  Shigeru Ohtsubo; Aritoshi Iida; Kosaku Nitta; Toshihiro Tanaka; Ryo Yamada; Yozo Ohnishi; Shiro Maeda; Tatsuhiko Tsunoda; Takashi Takei; Wataru Obara; Fumihiro Akiyama; Kyoko Ito; Kazuho Honda; Keiko Uchida; Ken Tsuchiya; Wako Yumura; Takashi Ujiie; Yutaka Nagane; Satoru Miyano; Yasushi Suzuki; Ichiei Narita; Fumitake Gejyo; Tomoaki Fujioka; Hiroshi Nihei; Yusuke Nakamura
Journal:  J Hum Genet       Date:  2004-12-14       Impact factor: 3.172

4.  Molecular size heterogeneity of immunoglobulins in health and disease.

Authors:  P J Roberts-Thomson; K Shepherd
Journal:  Clin Exp Immunol       Date:  1990-03       Impact factor: 4.330

5.  Defective hepatic handling of IgA immune aggregates by mice with experimental IgA nephropathy.

Authors:  E González; J González-Cabrero; J Egido
Journal:  Immunology       Date:  1989-07       Impact factor: 7.397

6.  Detection of monomeric and polymeric IgA containing immune complexes in serum and kidney from patients with alcoholic liver disease.

Authors:  J Sancho; J Egido; M Sánchez-Crespo; R Blasco
Journal:  Clin Exp Immunol       Date:  1982-02       Impact factor: 4.330

7.  Urinary IgA in IgA nephropathy and Henoch-Schoenlein purpura.

Authors:  J H Galla; M F Spotswood; L A Harrison; J Mestecky
Journal:  J Clin Immunol       Date:  1985-09       Impact factor: 8.317

8.  IgA1 and IgA2 immune complexes in primary IgA nephropathy and Henoch-Schönlein nephritis.

Authors:  R Coppo; B Basolo; G Piccoli; G Mazzucco; M R Bulzomì; D Roccatello; M De Marchi; A O Carbonara; G Barbiano di Belgiojoso
Journal:  Clin Exp Immunol       Date:  1984-09       Impact factor: 4.330

9.  Hepatic and kidney uptake of soluble monomeric and polymeric IgA aggregates.

Authors:  J Sancho; E González; F Rivera; J F Escanero; J Egido
Journal:  Immunology       Date:  1984-05       Impact factor: 7.397

10.  [Kidney involvement in liver diseases: morphology].

Authors:  G Syré
Journal:  Klin Wochenschr       Date:  1983-10-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.